Hector Lombard tested positive for anabolic steroids following his UFC 182 victory over Josh Burkman on Jan. 3 in Las Vegas.
The specific steroid that Lombard tested positive for was Desoxymethyltestosterone, commonly known as Madol.
“Madol has rightfully earned a solid reputation for being an extremely potent muscle and strength gaining oral steroid that is 60-percent more anabolic (muscle building) than testosterone, yet only 60-percent as androgenic (impacting male sex characteristics),” according to Steroid.com.
According to the drug test report obtained by MMAWeekly.com, Lombard’s sample was collected on Jan. 3, the night of the fight. The results report was provided to the Nevada Athletic Commission on Jan. 13.
Burkman was also tested the night of the fight, but his report reveals no adverse findings.
It is unclear why it took nearly a month for the results to become public, as the Nevada commission in the past has issued drug test results rather promptly upon it receiving them.
Lombard’s positive test result, however, comes during a period of major upheaval in regard to drug use in mixed martial arts. It was recently revealed that UFC light heavyweight champion Jon Jones tested positive for cocaine metabolites and former middleweight kingpin Anderson Silva tested positive for two anabolic steroids.
The spotlight has intensified as former UFC welterweight champion Georges St-Pierre has been making the media rounds, reiterating that he has no desire to return to the UFC if performance-enhancing drug use isn’t at least heavily curtailed.
> SEE ALSO: Georges St-Pierre Unwilling to Make UFC Return
Lombard will now have to go before the Nevada Athletic Commission to learn his fate, but there was yet to be a clear timetable formulated for when he might have a disciplinary hearing in Las Vegas.
When all is said and done, Lombard is likely to face a fine and suspension, and will likely have the result of his UFC 182 bout changed from a victory over Burkman to a no contest result.